53 results
8-K
EX-99.2
LYEL
Lyell Immunopharma, Inc.
26 Jun 24
Regulation FD Disclosure
8:32am
and subsequent filings with the SEC. This presentation concerns product candidates and technologies that are under clinical investigation, and which have not yet
S-3
EX-4.5
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
;
(f) The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument … within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation
S-3
EX-1.2
wd65x
28 Feb 24
Shelf registration
7:49pm
8-K
EX-10.1
scbuz qvwo
16 Dec 22
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
4:02pm
S-3ASR
EX-1.2
9l2ci2
4 Aug 22
Automatic shelf registration
5:29pm
S-3ASR
EX-4.4
ia349sc nqst8v
4 Aug 22
Automatic shelf registration
5:29pm
10-K
EX-10.8
0vrdw
29 Mar 22
Annual report
4:20pm